Probi AB (publ) (STO: PROB)
Sweden
· Delayed Price · Currency is SEK
351.00
+105.00 (42.68%)
Nov 20, 2024, 5:29 PM CET
Probi AB Revenue
Probi AB had revenue of 143.71M SEK in the quarter ending September 30, 2024, a decrease of -7.90%. This brings the company's revenue in the last twelve months to 630.39M, up 2.41% year-over-year. In the year 2023, Probi AB had annual revenue of 627.69M with 1.52% growth.
Revenue (ttm)
630.39M
Revenue Growth
+2.41%
P/S Ratio
6.34
Revenue / Employee
4.02M
Employees
160
Market Cap
4.00B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 627.69M | 9.40M | 1.52% |
Dec 31, 2022 | 618.29M | -39.90M | -6.06% |
Dec 31, 2021 | 658.18M | -58.99M | -8.22% |
Dec 31, 2020 | 717.17M | 90.97M | 14.53% |
Dec 31, 2019 | 626.19M | 22.08M | 3.65% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 519.35B |
Swedish Orphan Biovitrum AB (publ) | 25.44B |
Sectra AB (publ) | 3.17B |
Getinge AB (publ) | 33.59B |
Camurus AB (publ) | 1.69B |
Vitrolife AB (publ) | 3.56B |
Medicover AB (publ) | 22.60B |
Elekta AB (publ) | 18.12B |